David Sheppard PhD., Head of Chemistry
Dr. Sheppard runs Anima's chemistry group from Cambridge, UK. He has over 18 years of experience in small molecule drug discovery. Prior to joining Anima, Dr. Sheppard was a Director at BioFocus, now part of the Charles River group, where he led, managed and motivated a group of computational and synthetic chemists along with leading drug discovery programs for external clients. The experience gained in working for a top global contract research organization (CRO) gave Dr. Sheppard a broad expertise in numerous therapeutic areas and emerging targets including those associated with the proteasome, epigenetic modulation and a diversity of compound classes including peptides, peptidomimetic, macrocyclic, fragment, reversible covalent and traditional small molecule inhibitors.
Before joining BioFocus, Dr. Sheppard worked for Medivir as a senior computational chemist and before that at Amgen. Dr. Sheppard obtained his degree in chemistry from the University of St Andrews, Scotland and he obtained his Ph.D. from the University of Manchester in 2000. Throughout his career, Dr. Sheppard has set up and managed numerous successful collaborations with academic groups, he has authored numerous high quality peer-reviewed publications and is a scientific reviewer for the Wellcome Trust.